Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Cooper's other long-term assets for the quarter that ended in Apr. 2026 was $2,668 Mil.
The Cooper's quarterly other long-term assets
declined
from Oct. 2025 ($2,767 Mil) to Jan. 2026 ($2,727 Mil) but then
stayed the same
from Jan. 2026 ($2,727 Mil) to Apr. 2026 ($2,668 Mil).
The Cooper's annual other long-term assets
declined
from Oct. 2023 ($2,987 Mil) to Oct. 2024 ($2,871 Mil) and
declined
from Oct. 2024 ($2,871 Mil) to Oct. 2025 ($2,767 Mil).
The historical data trend for The Cooper's Other Long Term Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.
What does a Other Long Term Assets of $2,668 Mil mean?
The Cooper (COO) has a Other Long Term Assets of $2,668 Mil as of Apr. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on The Cooper and its competitors.
Is The Cooper's Other Long Term Assets too high?
The Cooper's current Other Long Term Assets is $2,668 Mil. Overall, The Cooper has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Other Long Term Assets compare to SOLV and ALGN?
The Cooper's Other Long Term Assets of $2,668 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Devices & Instruments company?
A good Other Long Term Assets depends on the Medical Devices & Instruments industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on The Cooper and its competitors. The Cooper's current Other Long Term Assets is $2,668 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Modestly Undervalued. The stock's GF Value™ is $101.54, compared to a current price of $74.23 — trading 26.9% below its estimated fair value. The current Other Long Term Assets is $2,668 Mil. The Cooper's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For The Cooper (COO), the current Other Long Term Assets is $2,668 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cooper (COO) Overvalued in 2026?
Based on GuruFocus' analysis, The Cooper stock appears to be undervalued.
The current stock price of $74.23 is trading 26.9% below its estimated GF Value™ of $101.54.
GuruFocus considers The Cooper to be Modestly Undervalued.
Key valuation signals for COO:
Other Long Term Assets: $2,668 Mil
GF Value™: $101.54 vs. price of $74.23 (26.9% below fair value)
No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
90GF Score
Get the complete analysis for COO
Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COO has been successfully added to your 
